Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about atopic dermatitis
Recent news which mentions atopic dermatitis
Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis
April 11, 2022
Tickers
LLY
Tags
Market News
Benzinga
LLY
From
Benzinga
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
April 07, 2022
Tickers
VYNE
Tags
Market News
Phase 2 Trial
Trading Ideas
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
General
SNY
News
From
Benzinga
ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
January 21, 2022
Tickers
ASLN
Tags
News
Briefs
Movers
From
Benzinga
FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
January 18, 2022
Tickers
ABBV
Tags
Biotech
atopic dermatitis
ABBV
From
Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
November 30, 2021
Tickers
HOTH
Tags
News
General
Exclusives
From
Benzinga
Connect Biopharma's Mid-Stage Atopic Dermatitis Trial Meets Primary Endpoint
November 19, 2021
Tickers
CNTB
Tags
Movers
News
Briefs
From
Benzinga
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
September 30, 2021
Tickers
ABBV
Tags
Benzinga
Market News
Phase 3
From
Benzinga
Pfizers' JAK Inhibitor Approved In Japan For Atopic Dermatitis
September 30, 2021
Tickers
PFE
Tags
General
Health Care
News
From
Benzinga
Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
September 27, 2021
Tickers
ASLN
Tags
Movers
why it's moving
News
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Market News
Trading Ideas
FDA
From
Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
Tickers
PFE
REGN
SNY
Tags
General
Phase 3 Trial
Briefs
From
Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
August 30, 2021
Tickers
REGN
SNY
Tags
Phase 3 Results
atopic dermatitis
Biotech
From
Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
August 16, 2021
Tickers
LLY
Tags
Market News
Benzinga
LLY
From
Benzinga
VYNE Therapeutics Stock Drops On Potential Sale Of Topical Minocycline Franchise
August 12, 2021
Tickers
VYNE
Tags
Asset Sales
Market News
Benzinga
From
Benzinga
FDA Will Not Meet Goal Dates For Pfizer's Xeljanz, Abrocitinib Applications
July 22, 2021
Tickers
PFE
Tags
Health Care
General
atopic dermatitis
From
Benzinga
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
July 16, 2021
Tickers
ABBV
INCY
LLY
Tags
INCY
News
Briefs
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.